The Neuromuscular Disease Network for Canada


The BRAIN Conference | Two-day online conference

BRAIN has published landmark papers in clinical neurology and translational neuroscience since 1878. The Guarantors of BRAIN are devoted to promoting teaching, education & research in neurology and related disciplines.

BRAIN and its Guarantors are excited to announce a new venture: The BRAIN Conference! This two-day conference will feature a selection of fantastic speakers, invited by our conference Chairs from around the globe.

They will deliver clinical teaching talks and research presentations across the range of neurology, neuropsychiatry and neuroscience.

This conference will take place on March 4-5th 2021 and be fully online.
The following areas will be covered:

Cognitive Neurology (Chair: Masud Husain)
Epilepsy (Chair: Dimitri Kullman)
Neurodegenerative (Chair: Anne Rosser),
Neurogenetics (Chair: Nicholas Wood),
Headache (Chair: Peter Goadsby),
Traumatic Brain Injury (Chair: Dave Sharp),
Nerve (Chair: Mary Reilly),
Stroke (Chair: Hugh Markus),
Neuroinflammation/MS (Chair: Olga Ciccarelli),
Movement Disorders (Chair: Anette Schrag),
Infectious Disease (Chair: Tom Solomon),
Neuropsychiatry (Chair: Paul Fletcher),
COVID Neurology (Chair: Mike Zandi) and
Muscle (Chair: Mike Hanna)

There will also have short ‘data blitz’ presentations in these sessions – BRAIN encourages all early-career researchers to submit an abstract to be considered.
Abstract submission now open!

BRAIN is keen to make this conference accessible to all – registration is only GBP 10 [free if you cannot afford this].


Register Now


Follow BRAIN: a journal of neurology @Brain1878
Visit the BRAIN Conference website for registration and program information:

Read next...

JND treatabolome

Treatabolome Project Designed to Shorten Diagnosis-to-Treatment Time for Patients with Rare Diseases

The NMD4C would like to share the publication of a special issue of the Journal of Neuromuscular Disease dedicated to the Treatabolome, a new online database for rare disease and gene-specific treatment information. The special issue includes six systematic reviews contributed by experts on rare neurological disorders.


Neuromuscular Research Funding Announcements From Jesse’s Journey and Muscular Dystrophy Canada

The NMD4C is excited to share recent grant funding announcements from two of our partners, Jesse’s Journey and Muscular Dystrophy Canada. Jesse’s Journey will grant $1.7M toward four promising research projects this year. Muscular Dystrophy Canada (MDC) will invest $400,000 towards seven new research projects through the MDC Neuromuscular Disorder (NMD) Research Grant Competition and through the European Joint Programme on Rare Diseases (EJP RD).

newborn screeningMay

Muscular Dystrophy Canada Announce Phase 2 of Newborn Screening Initiatives with Call for Funding Proposals

MDC is excited to launch Phase 2 of their work with a call for proposals for local newborn screening for SMA initiatives. It is anticipated that these projects will be led by labs or clinicians (or both) and should either focus on setting the lab up for testing or ensuring efficient uptake of policy (i.e., addition of SMA to existing provincial newborn screening panel).

EC Update

Early Career Working Group Update

the NDM4C has created a list of profiles for these members, where you can learn more about their research interests, publications, and where you can find them online. The NMD4C has also launched an early-career Slack channel, and are seeking early career member representation on our work packages.


Read Dr. Louise Moyle’s Early Career Blog

Read the latest early career blog post, from NMD4C member Dr. Louise Moyle. 


Jesse’s Journey Grants $1.7 Million to Duchenne Muscular Dystrophy Research

Jesse’s Journey, Canada’s leader in Duchenne muscular dystrophy funded research, will grant $1.7M toward four promising research projects this year.